Becton, Dickinson and Company (BIT:1BDX)
Italy · Delayed Price · Currency is EUR | Market Cap | 35.07B -29.8% |
| Revenue (ttm) | 19.28B +6.5% |
| Net Income | 987.85M -24.0% |
| EPS | 3.46 -22.8% |
| Shares Out | n/a |
| PE Ratio | 35.50 |
| Forward PE | 11.33 |
| Dividend | 2.70 (2.18%) |
| Ex-Dividend Date | Mar 9, 2026 |
| Volume | 47 |
| Average Volume | 4 |
| Open | 129.35 |
| Previous Close | 123.75 |
| Day's Range | 129.35 - 129.35 |
| 52-Week Range | 123.60 - 180.90 |
| Beta | n/a |
| RSI | 33.14 |
| Earnings Date | May 7, 2026 |
About BIT:1BDX
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, va... [Read more]
Financial Performance
In fiscal year 2025, BIT:1BDX's revenue was $21.84 billion, an increase of 8.24% compared to the previous year's $20.18 billion. Earnings were $1.68 billion, a decrease of -1.58%.
Financial numbers in USD Financial StatementsNews
Becton, Dickinson and Company Earnings Call Transcript: Q2 2026
Q2 revenue rose 2.6% to $4.7B, with strong growth in key platforms and adjusted EPS of $2.90. Full-year adjusted EPS guidance was raised to $12.52–$12.72, reflecting broad-based execution and improved outlook. Share repurchases and innovation remain capital priorities.
Becton Dickinson raises annual profit forecast on strength in drug delivery devices
Becton Dickinson raised its annual profit forecast on Thursday, riding strong demand for its drug-delivery devices and surgical equipment, and appointed Vitor Roque as its chief financial officer.
BD Appoints Vitor Roque Chief Financial Officer
FRANKLIN LAKES, N.J., May 7, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Vitor Roque has been named executive...
BD Reports Second Quarter Fiscal 2026 Financial Results
Revenue of $4.7 billion increased 5.2% as reported, 2.6% FXN GAAP and adjusted diluted EPS from continuing operations of $(0.13) and $2.90, respectively Executed a $2.0 billion accelerated share repur...
BD and Wellstar Advance Patient Care and Safety with Medication Management Powered by AI
By integrating the BD Pyxis™ Pro and BD Alaris™ platforms, Wellstar Health System is giving clinicians clearer insight, greater accuracy and simple automation, so they can focus on delivering safer, m...
BD Achieves Excellence in Employee Well‑Being, Earning Top Industry Recognition
Business Group on Health, Cigna Healthcare, and the American Heart Association highlight BD's comprehensive and innovative approach to advancing employee health and well being FRANKLIN LAKES, N.J., Ap...
BD Reimagines Central Line Insertion, Advancing Leadership in Patient Safety Through Breakthrough Vascular Access Technology
With the launch of CentroVena One™, BD brings a first ‑ of ‑ its ‑ kind insertion system to market that simplifies central line placement for clinicians and enhances care in acute settings FRANKLIN LA...
BD Board Declares Dividend
FRANKLIN LAKES, N.J., April 28, 2026 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has decla...
BD to Present at Bank of America Securities Health Care Conference
FRANKLIN LAKES, N.J., April 27, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of Am...
BD Earns Industry Top Honors for Transparency, Resiliency and Partnership
FRANKLIN LAKES, N.J., April 16, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has been recognized by the Healthcare Industry Resilie...
BD to Announce Financial Results for its Second Quarter of Fiscal 2026
FRANKLIN LAKES, N.J., April 9, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio w...
Rick Byrd to Retire from BD
FRANKLIN LAKES, N.J., April 9, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Richard (Rick) Byrd has informed t...
For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD® PureWick® Urine Collection System
New study findings published in the Journal of Clinical Medicine highlight the ease of use and comfort of BD PureWick® Female External Catheter can support a better night's rest FRANKLIN LAKES, N.J. ,...
BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union
CE Marking and ARCH clinical trial data position the Liverty™ TIPS Stent Graft to expand treatment options for patients with advanced liver disease FRANKLIN LAKES, N.J., April 8, 2026 /PRNewswire/ -- ...
When Every Beat Matters, BD Helps Clinicians Eliminate Blind Spots with Continuous, Noninvasive Blood Pressure Insight
New HemoSphere Stream™ Module expands access to continuous, noninvasive arterial waveform data across compatible bedside monitors and broader care settings, giving more clinicians real-time insight in...
BD Launches AI-Enabled Medication Dispensing System to the European Market
Advanced automation and connected data capabilities strengthen medication inventory control and enhance safety across pharmacy settings. FRANKLIN LAKES, N.J.
Becton, Dickinson and Company Transcript: Barclays 28th Annual Global Healthcare Conference
Aggressive hedging and diversified sourcing insulate from oil and supply shocks, while strategic divestitures and tuck-in M&A have built new growth platforms. Alaris relaunch and connected care innovations drive competitive gains, with high-growth areas and AI integration supporting a positive outlook.
BD Pioneers New Standard in Surgical Safety with FDA-Cleared Surgiphor™ 1000mL for Wound Irrigation
The first and only innovation of its kind to receive 510(k) clearance, Surgiphor™ 1000mL empowers surgical teams with a consistent, antimicrobial solution designed to improve patient care and operatin...
Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase
FRANKLIN LAKES, N.J., Feb. 25, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) (the "Company" or "BD"), a leading global medical technology company, today announced the considerati...
Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap
FRANKLIN LAKES, N.J., Feb. 25, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) (the "Company" or "BD"), a leading global medical technology company, today announced the early tende...
BD to Present at Barclays 28th Annual Global Healthcare Conference
FRANKLIN LAKES, N.J., Feb. 23, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Barclays 28...
BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency
The BD Vacutainer® Urine Complete Cup Kit preserves specimen quality, streamlines testing, and helps reduce repeat collections to support better patient care FRANKLIN LAKES, N.J., Feb. 23, 2026 /PRNew...
Lanesha Minnix Named General Counsel for BD
FRANKLIN LAKES, N.J., Feb. 19, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Lanesha Minnix has been named exec...
What's Going On With Becton Dickinson Stock Tuesday?
The company reported sales of $5.25 billion, slightly above the consensus of $5.15 billion.
Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities
FRANKLIN LAKES, N.J., Feb. 10, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) (the "Company" or "BD"), a leading global medical technology company, today announced that it has com...